Artículos por temáticas

Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease

Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Cedarbaum JM, Orr-Urtreger A, Shenhar-Tsarfaty S, Mirelman A.

J Neurol. 2021 Apr;268(4):1517-1525. doi: 10.1007/s00415-020-10325-4. Epub 2021 Jan 3.

Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit

Yu Z, Li Y; and the Parkinson's Progression Markers Initiative.

Medicine (Baltimore). 2021 Feb 19;100(7):e24837. doi: 10.1097/MD.0000000000024837.

Intrinsic Disruption of the M1 Cortical Network in a Mouse Model of Parkinson's Disease

Aeed F, Cermak N, Schiller J, Schiller Y.

Mov Disord. 2021 Jul;36(7):1565-1577. doi: 10.1002/mds.28538. Epub 2021 Feb 19.

The effectiveness of specialized nursing interventions for patients with Parkinson disease: A randomized controlled study protocol

Chen Y, Lu T, Jiang X, Huang X.

Medicine (Baltimore). 2021 Jan 15;100(2):e23972. doi: 10.1097/MD.0000000000023972.

Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models

Jin JW, Fan X, Del Cid-Pellitero E, Liu XX, Zhou L, Dai C, Gibbs E, He W, Li H, Wu X, Hill A, Leavitt BR, Cashman N, Liu L, Lu J, Durcan TM, Dong Z, Fon EA, Wang YT.

Commun Biol. 2021 Feb 19;4(1):232. doi: 10.1038/s42003-021-01746-6.

Induced Expression of kir6.2 in A1 Astrocytes Propagates Inflammatory Neurodegeneration via Drp1-dependent Mitochondrial Fission

Song N, Zhu H, Xu R, Liu J, Fang Y, Zhang J, Ding J, Hu G, Lu M.

Front Pharmacol. 2021 Jan 28;11:618992. doi: 10.3389/fphar.2020.618992. eCollection 2020.

Subthalamic deep brain stimulation induces finely-tuned gamma oscillations in the absence of levodopa

Wiest C, Tinkhauser G, Pogosyan A, He S, Baig F, Morgante F, Mostofi A, Pereira EA, Tan H, Brown P, Torrecillos F.

Neurobiol Dis. 2021 May;152:105287. doi: 10.1016/j.nbd.2021.105287. Epub 2021 Feb 5.

Validation of IMU-based gait event detection during curved walking and turning in older adults and Parkinson's Disease patients

Romijnders R, Warmerdam E, Hansen C, Welzel J, Schmidt G, Maetzler W.

J Neuroeng Rehabil. 2021 Feb 6;18(1):28. doi: 10.1186/s12984-021-00828-0.

Gastrointestinal dysfunction in movement disorders

Sakakibara R.

Neurol Sci. 2021 Apr;42(4):1355-1365. doi: 10.1007/s10072-021-05041-4. Epub 2021 Feb 4.

Evaluation of TH-Cre knock-in cell lines for detection and specific targeting of stem cell-derived dopaminergic neurons

Fiorenzano A, Birtele M, Wahlestedt JN, Parmar M.

Heliyon. 2021 Jan 20;7(1):e06006. doi: 10.1016/j.heliyon.2021.e06006. eCollection 2021 Jan.

Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders

Erskine D, Koss D, Korolchuk VI, Outeiro TF, Attems J, McKeith I.

Acta Neuropathol. 2021 Apr;141(4):511-526. doi: 10.1007/s00401-021-02266-7. Epub 2021 Jan 30.

Dopamine in Health and Disease: Much More Than a Neurotransmitter

Franco R, Reyes-Resina I, Navarro G.

Biomedicines. 2021 Jan 22;9(2):109. doi: 10.3390/biomedicines9020109.

Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities

Victorino DB, Nejm M, Guimarães-Marques M, Scorza FA, Scorza CA.

Pharmaceut Med. 2021 Jan;35(1):11-19. doi: 10.1007/s40290-020-00374-5. Epub 2021 Jan 7.

Current application and future directions of photobiomodulation in central nervous diseases

Yang M, Yang Z, Wang P, Sun Z.

Neural Regen Res. 2021 Jun;16(6):1177-1185. doi: 10.4103/1673-5374.300486.

Validation of the German Version of the New Freezing of Gait Questionnaire for People with Parkinson's Disease

Seuthe J, Kuball K, Hoffmann AK, Weisser B, Deuschl G, Schlenstedt C.

Parkinsons Dis. 2021 Jan 13;2021:8841679. doi: 10.1155/2021/8841679. eCollection 2021.